CD44 and cancer: None of the eligible studies for CD44 polymorphism rs11821102 indicate a positive correlation with statistical power associated with cancer; yet pooled analysis demonstrated that the minor allele of rs11821102 polymorphism might be related to a decreased cancer risk in Chinese.